Offer - Urjas Oil for just ₹ 1 X
Nebistar 10 Tablet (15) is a commercial drug that is prescribed in the form of Tablet. Primarily, it is used for the treatment of High BP.
The correct dosage of Nebistar 10 Tablet (15) depends on the patient's age, gender, and medical history. Individual symptoms and route of administration also determines the right dosage. Detailed information has been provided in the dosage section.
Some other side effects of Nebistar 10 Tablet (15) have been listed ahead. These side effects of Nebistar 10 Tablet (15) are usually temporary and subside with the completion of treatment. If, however, they worsen or do not go away, please speak with your physician.
In addition, Nebistar 10 Tablet (15)'s effect is Severe during pregnancy and Severe for lactating mothers. In addition, Nebistar 10 Tablet (15)'s effects on the liver, heart and kidney are discussed below in the Nebistar 10 Tablet (15) related warnings section.
Nebistar 10 Tablet (15) is not recommended if you suffer from certain medical conditions as it can have adverse effects. Diabetes, Asthma, COPD (Chronic Obstructive Pulmonary Disease) are examples of such conditions. Other contraindications of Nebistar 10 Tablet (15) have been discussed in the sections ahead.
Drug interactions for Nebistar 10 Tablet (15) have been reported in the medical literature. Refer to the list below for further details.
In addition to the above precautions for Nebistar 10 Tablet (15), it is important to know that it is not safe while driving, and is not habit-forming.
Nebistar 10 Tablet (15) is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Nebistar 10 Tablet (15) safe for pregnant women?
Nebistar shows severe side effect on pregnant women. For this reason, pregnant women should only take it after taking medical advice.
Is the use of Nebistar 10 Tablet (15) safe during breastfeeding?
Women who are breastfeeding may experience severe harmful effects after taking Nebistar. It should only be taken after medical advice.
What is the effect of Nebistar 10 Tablet (15) on the Kidneys?
Nebistar rarely affects the kidneys.
What is the effect of Nebistar 10 Tablet (15) on the Liver?
Very few cases of side effects of Nebistar on the liver have been reported.
What is the effect of Nebistar 10 Tablet (15) on the Heart?
Nebistar may have mild side effects on the heart. Most people will never see any effect on the heart.
If you are suffering from any of the following diseases, you should not take Nebistar 10 Tablet (15) unless your doctor advises you to do so -
Is this Nebistar 10 Tablet (15) habit forming or addictive?
Nebistar 10 Tablet (15) is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
After taking Nebistar 10 Tablet (15) you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Yes, but take Nebistar 10 Tablet (15) only as per medical advice.
Is it able to treat mental disorders?
No, Nebistar 10 Tablet (15) is not used to treat mental disorders.
Interaction between Food and Nebistar 10 Tablet (15)
Eating certain foods may increase the time it takes Nebistar 10 Tablet (15) to have an effect. You should consult your doctor about it.
Interaction between Alcohol and Nebistar 10 Tablet (15)
Consult your doctor before consuming alcohol while taking Nebistar 10 Tablet (15) as it can have severe side effects.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Bystolic® (nebivolol)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 149-151
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 896-897